Journals / Türk Biyokimya Dergisi / 2019 / Cilt: 44 - Sayı: 2

Importance of biochemical parameters in order to predict clinical severity in patients diagnosed with Crimean-Congo haemorrhagic fever

Kırım kongo kanamalı ateşi tanılı hastalarda klinik şiddeti tahmin etmede biyokimyasal parametrelerin önemi

Pages
177–181
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, CPK, CRP, MPV and RDW values were notobserved to be important for prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to investigate new biochemical indicators to predict the clinical course of patients following thediagnosis of Crimean-Congo haemorrhagic fever (CCHF).Material and methods: We retrospectively evaluatedpatients diagnosed with CCHF.
📊
Key Findings & Data:Thesebiochemical parameters may predict the clinical course ofour three patient groups.Results: In our study, there were 38 (70.4%) maleand 16 (29.6%) female patients, and the mean agewas 44.33 ± 16.94 years.
💡
Conclusion & Impact:However, CPK, CRP, MPV and RDW values were notobserved to be important for prognosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed to investigate new biochemical indicators to predict the clinical course of patients following thediagnosis of Crimean-Congo haemorrhagic fever (CCHF).Material and methods: We retrospectively evaluatedpatients diagnosed with CCHF. They were divided intothree groups based on a scoring system known as severitygrading score in order to predict severity. Red cell distribution width (RDW), mean platelet volume (MPV), creatinine phosphokinase (CPK), alkaline phosphatase (ALP),glutamyl transferase (GGT) and C-reactive protein (CRP)levels were evaluated on the first day of admission. Thesebiochemical parameters may predict the clinical course ofour three patient groups.Results: In our study, there were 38 (70.4%) maleand 16 (29.6%) female patients, and the mean agewas 44.33 ± 16.94 years. Based on our scoring system,17 (31.4%), 30 (55.5%) and 7 (12.9%) patients were in group1, 2 and 3, respectively. Statistically significant differencewas observed between groups 1–3 and groups 2–3 for ALPvalues; however, a statistically significant difference wasobserved among all three groups for GGT values. Significant differences were not observed among the groups forRDW, MPW, CPK and CRP levels (p > 0.05).Conclusion: ALP and GGT values can be used as auxiliaryindicators to predict the clinical course for patients withCCHF. However, CPK, CRP, MPV and RDW values were notobserved to be important for prognosis.

Özet

Amaç: Kırım Kongo kanamalı ateşi (KKKA), insanlarda görülen en sık kene ile ilişkili hastalıktır. Çalışmamızda KKKA tanısı ile takip edilen hastaların klinik seyrini ön görmek için yeni belirteçlerin araştırılması amaçlanmıştır. Materyal ve metod: Bu çalışmada 2011–2017 tarihleri arasında KKKA tanısı ile takip ettiğimiz hastalar retrospektif olarak değerlendirildi. Klinik şiddeti tahmin etmede kullanılan skorlama sistemine göre hastalar üç ayrı gruba ayrıldı. Gruplar arasında klinik seyri tahmin etmede yararlı olabileceği düşünülen hastaneye başvuru gününde saptanan eritrosit dağılım genişliği (RDW), ortalama trombosit hacmi (MPV), kreatinin fosfokinaz (CPK), alkalen fosfataz (ALP), gama glutamil transferaz (GGT) ve C-reaktif protein (CRP) düzeyleri değerlendirildi. Bulgular: Çalışmamıza dahil edilen 54 olgunun 38 (%70.4)’i erkek, 16 (%29.6)’sı kadındı. Yaş ortalaması 44.33 ± 16,94 bulundu. Hastaların 17 (%31,4)’si grup 1’de, 30 (%55,5)’u grup 2’de, 7 (%12,9)’si ise grup 3’te yer aldı. Gruplar arası karşılaştırmada ALP değerleri açısından grup 1–3 ve grup 2–3 arasında, GGT düzeyleri açısından ise tüm gruplar arasında istatistiksel olarak anlamlı fark saptandı. Gruplar arasında RDW, MPV, CPK, CRP düzeyleri açısından anlamlı farklılık gözlenmedi (p > 0.05). Sonuç: Klinik seyri tahmin etmede kullanılan skorlama sisteminde ALP ve GGT değerleri de yardımcı marker olarak kullanılabilir. Ancak CPK, CRP, MPV, RDW değerleri prognoz açısından önemli bulunmamıştır.

🔖

Cite This Article

DEMİRDAĞ, K., AKBULUT, A., TARTAR, A. S., BALİN, Ş. Ö., ÇATAK, Z. (2022). Importance of biochemical parameters in order to predict clinical severity in patients diagnosed with Crimean-Congo haemorrhagic fever. Türk Biyokimya Dergisi, Cilt: 44 - Sayı: 2, 177–181. https://ajindex.com/articles/620867

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res 2013;100:159–89
  2. Appannanavar SB, Mishra B. An update on Crimean Congo hemorrhagic Fever. J Glob Infect Dis 2011;3:285–92
  3. Öngürü P, Bodur H. Kırım Kongo Kanamalı Ateşi. J Exp Clin Med 2012;29:175–81
  4. Hatipoglu CA, Bulut C, Yetkin MA, Ertem GT, Erdinc FS, Kilic EK, et al. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey. Scand J Infect Dis 2010;42:516–21
  5. Uyar Y, Çarhan A, Albayrak N, Altaş AB. Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey. Mikrobiyol Bul 2010;44:57–64
  6. Bodur H, Akinci E, Ascioglu S, Öngürü P, Uyar Y. Subclinical infections with Crimean-Congo hemorrhagic fever virus. Turk Emerg Infect Dis 2012;18:640–2
  7. Bakir M, Gözel MG, Köksal I, Aşik Z, Günal O, Yilmaz H, et al. Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with CrimeanCongo hemorrhagic fever (CCHF). Eur J Clin Microbiol Infect Dis 2015;34:325–30
  8. Lippi G, Targher G, Montagnana M, Salvaqno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009;133:628–32
  9. Küçükbayrak A, Taş T, Tosun M, Aktaş G, Hakyemez İN, Mengeloğlu FZ. Erythrocytes parameters in the course of brucellosis. Abant Med J 2013;2:36–9
  10. Leblebicioğlu H, Özaras R, Irmak H, Sencan I. Crimean-Congo hemorrhagic fever in Turkey: current status and future challenges. Antiviral Research J 2016;126:21–34
  11. Yağci-Çağlayik D, Korukluoğlu G, Uyar Y. Seroprevalence and risk factors of Crimean-Congo hemorrhagic fever in selected seven provinces in Turkey. J Med Virol 2014;86:306–14
  12. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006;6:203–14
  13. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989;11 (Suppl 4):794–800
  14. Çevik MA, Erbay A, Bodur H, Gülderen E, Baştuğ A, Kubar A, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008;12:374–9
  15. Korkmaz M, Yıldırım Y,